The Law Office of Hakimi & Shahriari
7080 Hollywood Blvd., Suite 804
Los Angeles, California 90028
Toll-Free: (888) 635 - 2250
Fax: (213) 402 - 2170
Summary of Existing Litigation
More than 1,500 former players claim that NFL teams and their training staffs dispensed powerful drugs such as Toradol (ketorolac) or “Vitamin T” while misleading them about the potential health risks. They claim that the NFL has fostered a culture of misuse of prescription pain killers by directly and indirectly supplying players with, among other things, the following types of prescription pain killers:
NSAIDs (Toradol); and
local anesthetics (Lidocaine).
The drugs are allegedly often administered without a prescription and little regard for a player’s medical history of potentially-fatal interactions with other drugs. Administering drugs in such a manner constitutes a fundamental misuse of this carefully-controlled prescription medication and a clear danger to the players.
The distribution of controlled substances and prescription drugs by team trainers without the required individual doctor-patient relationship may have violated federal law and other ethical medical standards.
While the former players’ case sought class-action status, it laid out the claims of 14 defendants against all 32 teams.
District Judge William Alsup dismissed the bulk of those claims, saying players “failed to demonstrate that their present-day medical ailments are tied to the medications they received during their playing careers.”
Claims were dismissed with the exception of claims of intentional misrepresentation against the Green Bay Packers, Denver Broncos and Los Angeles Chargers.
In a summary judgment ruling issued in July 2017, Alsup found retired football players could only seek relief through workers’ compensation, because their claims against three NFL teams did not fall within a narrow “intentional harm” exception.
It was the second painkillers class action against the NFL and its teams to be thrown out of court by Alsup, who dismissed an earlier suit, Dent v. NFL, in 2014, finding those claims were subject to arbitration under collective bargaining agreements.
BELOW IS A SUMMARY OF EXISTING LITIGATION GENERALLY RELATED TO THE USE AND ABUSE OF PHARMACEUTICAL DRUGS IN THE NATIONAL FOOTBALL LEAGUE (THE "NFL").
OUR FIRM IS NOW REPRESENTING CLIENTS OUTSIDE OF THE LITIGATION DISCUSSED BELOW.
IF YOU OR A LOVED ONE PLAYED IN THE NFL, USED TORADOL OR OTHER DRUGS WHILE PLAYING IN THE NFL AND ARE NOW SUFFERING FROM HEALTH ISSUES, PLEASE CALL OUR FIRM (888) 635 - 2250 FOR A FREE CONSULTATION.
ATTORNEY ADVERTISING - THE LAW OFFICE OF HAKIMI & SHAHRIARI
(888) 635 - 2250
Nothing on this site should be taken as legal advice for any individual case or situation. Every claim and potential legal claim must be viewed on its own merits. The information on this website is for general information purposes only. It is not intended to create, and receipt or viewing of this information does not constitute, an attorney-client relationship. Every situation and every client’s legal matter is different and this website is merely meant to provide information to the public. Nor does this website create an attorney-client relationship – such a relationship has not been formed unless a signed fee agreement has been made. If you want legal advice or want to know if you have suffered a legal wrong contact the attorneys at The Law Office of Hakimi & Shahriari at (888) 635 - 2250.